H353 · Sickle Cell Disease Treatment of Pain Continuing Education

2026 Session
Last action March 11, 2026

Sickle Cell Disease Treatment of Pain Continuing Education; Revises requirements for continuing education course on prescribing controlled substances.

Laid on Table; Companion bill(s) passed, see CS/SB 844 (Ch. 2026-6 ) Effective July 1, 2026 View original ↗